Shu‐Wen Lin
- Infectious Diseases top 5%
- Epidemiology top 10%
- Pharmacology top 5%
- Clinical Biochemistry top 5%
- Molecular Biology
- Co-authors
- Ching‐Hua KuoHsin‐Yun SunPeggy L. CarverI‐Lin TsaiGuan‐Yuan ChenChien‐Ching HungDaryl D. DePestelLi‐Jiuan Shen
- Topics
- Pneumocystis jirovecii pneumonia detection and treatment (13 papers)Antibiotics Pharmacokinetics and Efficacy (13 papers)HIV/AIDS drug development and treatment (12 papers)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Shu‐Wen Lin
73 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 116
- Infectious Diseases 419
- Epidemiology 274
- Pharmacology 260
- Clinical Biochemistry 129
- Molecular Biology 124
Countries citing papers authored by Shu‐Wen Lin
This map shows the geographic impact of Shu‐Wen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Wen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Wen Lin more than expected).
Fields of papers citing papers by Shu‐Wen Lin
This network shows the impact of papers produced by Shu‐Wen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Wen Lin. The network helps show where Shu‐Wen Lin may publish in the future.
Co-authorship network of co-authors of Shu‐Wen Lin
This figure shows the co-authorship network connecting the top 25 collaborators of Shu‐Wen Lin. A scholar is included among the top collaborators of Shu‐Wen Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu‐Wen Lin. Shu‐Wen Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 5 | |
| 7 | 6 | |
| 8 | 1 | |
| 9 | 13 | |
| 10 | 3 | |
| 11 | 21 | |
| 12 | 30 | |
| 13 | 7 | |
| 14 | 6 | |
| 15 | 10 | |
| 16 | 22 | |
| 17 | 2 | |
| 18 | 5 | |
| 19 | 24 | |
| 20 | Age, dementia and care patterns after admission for acute coronary syndrome: an analysis from a nationwide cohort under the National Health Insurance coverage. | 2 |
About Shu‐Wen Lin
Shu‐Wen Lin is a scholar working on Infectious Diseases, Virology and Applied Microbiology and Biotechnology, having authored 76 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pneumocystis jirovecii pneumonia detection and treatment (13 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers) and HIV/AIDS drug development and treatment (12 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (54 citations), Molecular Medicine (122 citations) and Infectious Diseases (419 citations). Shu‐Wen Lin has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Ching‐Hua Kuo, Hsin‐Yun Sun, Peggy L. Carver, I‐Lin Tsai, Guan‐Yuan Chen, Chien‐Ching Hung, Daryl D. DePestel, Li‐Jiuan Shen, Chi‐Chuan Wang and Chien‐Chih Wu. Their work appears in journals such as PLoS ONE, Analytical Chemistry and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.